Physicists have long wondered if the laws of quantum mechanics also apply to the ‘classical’ world. The EU-funded CAVITYQPD project has shown quantum entanglement between macroscale objects. Harnessing the quantum behaviour of everyday objects could propel citizens from the digital to the quantum age, facilitating our lives with vastly more sophisticated technologies.
The many microscopic organisms, or microbiome, that live in our gut play a big part in keeping us healthy, yet a breakdown in communication between them and the rest of the body can badly affect our health. The EU-funded META-BIOME project set out to understand the causes of this miscommunication. To understand this could allow for new treatments against many diseases, benefiting all citizens.
The EU-funded POTENT project has been developing a new type of drug delivery system for glioblastoma, an aggressive form of brain cancer. It can considerably improve treatment outcomes for patients and increase their life expectancy. Clinical trials could start in 2 to 4 years, a step closer to making the system available for the patients that could most benefit from it.
Reacting efficiently to natural disasters calls for extensive training, effective technologies and well-oiled strategies. The EU-funded DRIVER+ project provides just the means to these ends, due to its unique test bed and portfolio of solutions. Trials in four European countries already show much promise and will help contribute to ensuring citizens' safety.
Although being stuck in a brain scanner while being exposed to a horror film may not be everyone's idea of fun, monitoring volunteers' grey cells throughout this process can tell scientists a lot. EU-funded research using this and other memorable techniques has generated new knowledge on the way we process and transmit social information.
Until recently, there was no treatment specific to alpha-mannosidosis, one of the many rare diseases that jointly affect some 30 million citizens in Europe alone. Today, there is as EU-funded research developed enzyme-replacement therapy to stop the illness in its tracks, and this medicine is on the market.
What is the best way to tackle sarcomas? Although clinical trials help to generate insight, they are hard to set up for rare diseases. An EU-funded project has organised several trials focusing on these malignancies, providing insight that is already helping to save more lives. It has also paved the way for further research to help patients.